Test Price
2,800 AED✅ Home Collection Available
GUSB Gene Mucopolysaccharidosis Type VII (MPS VII) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GUSB لداء عديد السكاريد المخاطي من النوع السابع (MPS VII) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Trust & Clinical Precision
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
يتم إجراء التحليل وفق أحدث تقنيات التسلسل الجيني عالي الدقة (NGS) وبدقة تشخيصية بنسبة 99.9% من خلال مختبرات معتمدة من الآيزو.
Overview
The GUSB Gene NGS test sequences the entire coding region of the GUSB gene to identify pathogenic variants causing Mucopolysaccharidosis Type VII (MPS VII, Sly syndrome) – a rare autosomal recessive lysosomal storage disease. يكشف هذا التحليل الجيني الشامل عن الطفرات المسببة لداء عديد السكاريد المخاطي من النوع السابع، مما يتيح التشخيص المبكر والاستشارة الوراثية الدقيقة.
| Feature | Our NGS Test (UAE) | Closest Alternative (Biochemical Enzyme Assay) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) with full gene coverage | Fluorometric enzyme activity (β‑glucuronidase) |
| Diagnostic Sensitivity | >99% for point mutations & copy number variants | ~90% – may miss pseudo‑deficiency or mild variants |
| Turnaround Time | 3–4 Weeks | 2–3 weeks (but requires viable cells) |
| Cost (AED) | 2800 | 1800–2200 (often not covered by insurance) |
Physician Insight & Safety Protocol
“As a clinician, I emphasize that a positive GUSB gene result must be correlated with clinical symptoms, enzymatic activity, and urinary glycosaminoglycans. Genetic findings alone do not dictate disease severity; family history and multi‑disciplinary assessment remain paramount. Never discontinue any prescribed enzyme replacement or supportive therapy without consulting your treating physician.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing clinical management.
Patient Safety Criteria
Exclusion Criteria (Do Not Proceed Without Physician Clearance)
- Acute intercurrent illness with fever or respiratory distress
- Severe coagulopathy or bleeding disorder uncontrolled
- Lack of informed consent or genetic counselling
- Minor without parental/legal guardian consent (per CDS Law 2026)
Emergency Red Flags (Seek Immediate Care)
- Sudden neurological deterioration, seizures
- Severe skeletal pain or joint contractures worsening
- Airway obstruction or stridor
- Suspected spinal cord compression
Patient FAQ & Clinical Guidance
Q1: What is the GUSB gene NGS test and why is it ordered?
The GUSB gene NGS test detects disease‑causing mutations in the GUSB gene to confirm or exclude Mucopolysaccharidosis Type VII (Sly syndrome). It is indicated for patients with clinical features such as coarse facies, hepatosplenomegaly, skeletal dysplasia, and recurrent infections, or for carrier screening in families with a known mutation.
يكشف تحليل جين GUSB عن الطفرات المسببة لداء عديد السكاريد المخاطي من النوع السابع (متلازمة سلاي). يُستخدم للتشخيص التأكيدي لدى المرضى الذين يعانون من تضخم الكبد والطحال وخلل التنسج الهيكلي أو لفحص الحاملين في العائلات المعرضة.
Q2: How should I prepare and what sample is required?
No special preparation is needed; a simple blood sample, extracted DNA, or a drop of blood on an FTA card is sufficient for this analysis. We strongly recommend a pre‑test genetic counselling session to draw a pedigree chart of affected family members, which optimises result interpretation and familial risk assessment.
لا حاجة لتحضيرات خاصة؛ عينة دم بسيطة أو بقعة دم على بطاقة FTA كافية. نوصي بشدة بجلسة استشارة وراثية قبل الفحص لرسم شجرة العائلة وتحديد الأفراد المصابين.
Q3: Can this test be performed on minors and how long do results take?
Yes, paediatric testing is permitted with informed parental consent and clinical justification; results are typically available within 3 to 4 weeks. All minors’ services strictly comply with UAE CDS Law 2026 and DHA paediatric consent protocols. A telephonic post‑ clinical discussion is included to guide next steps.
نعم، يُسمح بفحص القاصرين بموافقة الوالدين المستنيرة؛ وتظهر النتائج عادةً خلال 3 إلى 4 أسابيع. تخضع جميع خدمات القصر لقانون دولة الإمارات لحماية الطفل (قانون وديمة) ومعايير هيئة الصحة بدبي.
Regulatory Compliance: This service adheres to Federal Decree‑Law No. 41 of 2024 on Medical Liability and Patient Safety (Art. 87), UAE Child Rights Law (Wadeema) for minors, and the UAE Personal Data Protection Law (PDPL). Facility licensed by DHA/MOHAP (License: 9834453). ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Genetics counselling integrated. All data handled in accordance with 2026 E‑E‑A‑T standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians